Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells

被引：0
|
作者：
Masao Fujiwara
Kunihiko Izuishi
Takanori Sano
Mohammad Akram Hossain
Shoji Kimura
Tsutomu Masaki
Yasuyuki Suzuki
机构：
[1] Kagawa University,Department of Gastroenterological Surgery, Faculty of Medicine
[2] Kagawa University,Department of Pharmacology, Faculty of Medicine
[3] Kagawa University,Department of Gastroenterology and Neurology, Faculty of Medicine
来源：
Journal of Experimental & Clinical Cancer Research | / 27卷
关键词：
Pancreatic Cancer; Pancreatic Cancer Cell; Human Pancreatic Cancer Cell; Cell Death Detection ELISAPlus; Pancreatic Cancer Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Therapeutic potential of the PI3K inhibitor LY294002 and PARP inhibitor Talazoparib combination in BRCA-deficient triple negative breast cancer cells
    Eskiler, Gamze Guney
    Ozturk, Melek
    CELLULAR SIGNALLING, 2022, 91
  • [42] Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors
    Lai, Jin-Ping
    Sandhu, Dalbir S.
    Yu, Chunrong
    Moser, Catherine D.
    Hu, Chunling
    Shire, Abdirashid M.
    Aderca, Ileana
    Murphy, Linda M.
    Adjei, Alex A.
    Sanderson, Schuyler
    Roberts, Lewis R.
    LIVER INTERNATIONAL, 2010, 30 (10) : 1522 - 1528
  • [43] Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002 - Discussion
    Grant, Clive
    Kunnimalaiyaan, Muthusamy
    Kebebew, Electron
    Moley, Jeffrey F.
    SURGERY, 2006, 140 (06) : 1014 - 1015
  • [44] The phosphatidylinositol 3-kinase inhibitor LY294002 potently blocks Kv currents in beta cells via a direct mechanism
    El-Kholy, W
    MacDonald, P
    Lin, JH
    Wang, J
    Fox, J
    Light, P
    Wang, QH
    Tsushima, R
    Wheeler, M
    DIABETES, 2003, 52 : A368 - A368
  • [45] Degradation of IκBα in Activated RAW264.7 Cells is Blocked by the Phosphatidylinositol 3-Kinase Inhibitor LY294002
    S.J. Park
    S.C. Lee
    S.H. Hong
    H.M. Kim
    Cell Biology and Toxicology, 2002, 18 : 121 - 130
  • [46] Degradation of IκBα in activated RAW264.7 cells is blocked by the phosphatidylinositol 3-kinase inhibitor LY294002
    Park, SJ
    Lee, SC
    Hong, SH
    Kim, HM
    CELL BIOLOGY AND TOXICOLOGY, 2002, 18 (02) : 121 - 130
  • [47] An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model
    Duan, W
    Datiles, AMKA
    Leung, BP
    Vlahos, CJ
    Wong, WSF
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2005, 5 (03) : 495 - 502
  • [48] The phosphatidylinositol 3-kinase inhibitor LY294002 potently blocks Kv currents via a direct mechanism
    El-Kholy, W
    MacDonald, PE
    Lin, JH
    Wang, J
    Fox, JM
    Light, PE
    Wang, QH
    Tsushima, RG
    Wheeler, MB
    FASEB JOURNAL, 2003, 17 (02): : 720 - +
  • [49] The phosphoinositide 3-kinase inhibitor LY294002, decreases aminoacyl-tRNA synthetases, chaperones and glycolytic enzymes in human HT-29 colorectal cancer cells
    Mallawaaratchy, Duthika M.
    Mactier, Swetlana
    Kaufman, Kimberley L.
    Blomfield, Katherine
    Christopherson, Richard I.
    JOURNAL OF PROTEOMICS, 2012, 75 (05) : 1590 - 1599
  • [50] Phosphoinositide 3-kinase inhibitor LY294002 ameliorates the severity of myosin-induced myocarditis in mice
    Liu, H. S.
    Zhang, J.
    Guo, J. -L.
    Lin, C. Y.
    Wang, Z. -W.
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2016, 64 (01) : 21 - 27
12345